MicroRNAs in cardiovascular diseases: biology and potential clinical applications
- PMID: 20560047
- DOI: 10.1007/s12265-010-9172-z
MicroRNAs in cardiovascular diseases: biology and potential clinical applications
Abstract
Cardiovascular diseases represent one of the major causes for increasing rates of human morbidity and mortality across the world. This reinforces the necessity for the development of novel diagnostics and therapies for the early identification and cure of heart diseases. MicroRNAs are evolutionarily conserved small regulatory non-coding RNAs that regulate the expression of large number of genes. They are involved in several cellular pathophysiological pathways and have been shown to play a significant role in the pathogenesis of many disease states. Recent studies have correlated dysregulated miRNA expressions to diseased hearts and also shown the relevance of miRNA in growth, development, function, and stress responsiveness of the heart. The possibility of exploiting miRNAs to develop diagnostic markers or manipulating them to obtain therapeutic effects is very attractive since they have very specific targets in a particular cellular pathway. In this review we will summarize the role played by miRNAs in the heart and discuss the scope of utilizing miRNA-based strategies in the clinics for the benefit of mankind.
Similar articles
-
MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases.J Cardiovasc Transl Res. 2010 Jun;3(3):271-9. doi: 10.1007/s12265-010-9179-5. Epub 2010 May 5. J Cardiovasc Transl Res. 2010. PMID: 20560048 Review.
-
MicroRNAs in cardiac remodeling and disease.J Cardiovasc Transl Res. 2010 Jun;3(3):212-8. doi: 10.1007/s12265-010-9165-y. Epub 2010 Feb 17. J Cardiovasc Transl Res. 2010. PMID: 20560042 Review.
-
MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.Acta Pharmacol Sin. 2010 Jan;31(1):1-9. doi: 10.1038/aps.2009.175. Epub 2009 Dec 7. Acta Pharmacol Sin. 2010. PMID: 19966833 Free PMC article. Review.
-
MicroRNAs: role in cardiovascular biology and disease.Clin Sci (Lond). 2008 Jun;114(12):699-706. doi: 10.1042/CS20070211. Clin Sci (Lond). 2008. PMID: 18474027 Review.
-
MicroRNA in cardiovascular biology and disease.Adv Clin Exp Med. 2017 Aug;26(5):865-874. doi: 10.17219/acem/62915. Adv Clin Exp Med. 2017. PMID: 29068585 Review.
Cited by
-
Molecular mechanisms of diabetic cardiomyopathy.Diabetologia. 2014 Apr;57(4):660-71. doi: 10.1007/s00125-014-3171-6. Epub 2014 Jan 30. Diabetologia. 2014. PMID: 24477973 Free PMC article. Review.
-
A 2-decade bibliometric analysis of epigenetics of cardiovascular disease: from past to present.Clin Epigenetics. 2023 Nov 25;15(1):184. doi: 10.1186/s13148-023-01603-9. Clin Epigenetics. 2023. PMID: 38007493 Free PMC article. Review.
-
Relationship between the temporal profile of plasma microRNA and left ventricular remodeling in patients after myocardial infarction.Circ Cardiovasc Genet. 2011 Dec;4(6):614-9. doi: 10.1161/CIRCGENETICS.111.959841. Epub 2011 Sep 28. Circ Cardiovasc Genet. 2011. PMID: 21956146 Free PMC article.
-
Global microRNA profiles and signaling pathways in the development of cardiac hypertrophy.Braz J Med Biol Res. 2014 May;47(5):361-8. doi: 10.1590/1414-431x20142937. Epub 2014 May 2. Braz J Med Biol Res. 2014. PMID: 24728214 Free PMC article.
-
MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy.J Biol Chem. 2011 Apr 1;286(13):11837-48. doi: 10.1074/jbc.M110.194969. Epub 2011 Feb 10. J Biol Chem. 2011. PMID: 21310958 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources